查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1370921

体外毒理学测试市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按技术、按应用、方法、最终用户、地区、竞争细分

In-vitro Toxicology Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Technology, By Application, By Method, By End-User, By Region, Competition
出版日期: | 出版商: TechSci Research | 英文 183 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2022年，全球体外毒理学测试市场估值达到160.9亿美元，预计将呈现强劲增长，复合年增长率（CAGR）为9.66%，预计到2028年将达到278.8亿美元。测试涉及评估各种物质对生物体以外的生物系统的潜在毒性影响的科学过程。这些评估通常在受控实验室环境中使用试管、培养皿或人工系统进行，从而复製了拉丁术语“体外”，意思是“在玻璃中”。这种方法提供了对细胞、分子和生化层面的毒理学影响的深入了解，可作为评估化学物质、药物、化妆品和消费品安全性的宝贵工具，且不会伤害动物或人类。

主要市场驱动因素

对新药和化学品安全评估的需求不断增加

市场概况
预测期 2024-2028
2022 年市场规模 160.9亿美元
2028 年市场规模 278.8亿美元
2023-2028 年复合年增长率 9.66%
成长最快的细分市场 细胞培养技术
最大的市场 北美洲

评估新药和化学品安全性的需求不断增长是全球体外毒理学测试市场的主要驱动力。 FDA 和 EMA 等监管机构要求进行全面的安全评估才能获得批准。考虑到道德问题和理解的进步，体外测试提供了一种高效且经济高效的方法来满足这些要求。它与减少动物试验一致，并加速药物发现的安全性评估。

体外毒理学技术的进步

体外毒理学的技术进步有助于市场成长。细胞培养技术的创新，例如 3D 模型和晶片器官平台，提高了模拟组织复杂性的准确性。自动化、机器人技术、成像技术和微流体设备提高了测试效率、预测能力和生理相关性。

提高对安全测试重要性的认识

利害关係人对安全评估必要性的认识不断提高是推动市场的关键趋势。道德问题、消费者意识、监管指南和媒体报告促使产业和研究人员优先考虑安全评估。体外测试作为一种更具社会责任感的方法而受到重视。

主要市场挑战

生物系统的复杂性

复製生物系统内复杂的相互作用提出了挑战。体外模型通常无法再现系统效应和复杂的生理反应，限制了预测的准确性。

与某些端点的相关性有限

体外模型可能无法很好地捕捉一些多方面的毒理学终点。这种限制影响了传统动物试验的替代，并限制了在特定监管和研究背景下的应用。

长期和慢性影响

使用短期体外测定评估长期和慢性影响提出了挑战。长期暴露和累积效应的复杂性很难在有限的时间内复製。

主要市场趋势

个人化医疗应用

体外毒理学符合个人化医疗趋势，根据遗传和生理特征评估个体对毒物的反应。这种方法有助于风险评估，为治疗决策提供信息，并识别用于即时毒性监测的生物标记。

细分市场洞察

技术洞察

反应性细胞培养技术因其准确性而在市场上占据主导地位。在受控环境中模拟细胞反应有助于对各种化合物进行毒性测试。在进步和应用的推动下，该细分市场预计将经历最高的复合年增长率。

应用洞察

由于监管机构要求进行全面的安全评估，系统毒理学测试引领市场。这种方法无需动物测试即可预测对多个器官系统的潜在不利影响。它有助于药物开发和风险评估。

方法见解

细胞检测由于直接评估对人类细胞的毒性作用而占据主导地位。高通量能力和对细胞途径的机制洞察提高了效率和理解。

最终使用者见解

製药业是主要的最终用户。监管要求、安全评估和早期风险识别推动了药物开发中体外毒性测试的采用。

区域洞察

北美在先进的製药工业和严格的监管框架的支持下引领市场。该地区的安全测试意识、道德问题和技术进步有助于成长。

目录

第 1 章：产品概述

  • 市场定义
  • 市场范围
    • 涵盖的市场
    • 考虑学习的年份
    • 主要市场区隔

第 2 章：研究方法

  • 研究目的
  • 基线方法
  • 主要产业伙伴
  • 主要协会和二手资料来源
  • 预测方法
  • 数据三角测量与验证
  • 假设和限制

第 3 章：执行摘要

  • 市场概况
  • 主要市场细分概述
  • 主要市场参与者概述
  • 重点地区/国家概况
  • 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球体外毒理学测试市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依技术分类（细胞培养技术、高通量技术、分子影像、组学技术）
    • 按应用（全身性毒理学、皮肤毒性、内分泌干扰、眼部毒性、其他）
    • 依方法（细胞测定、生化测定、In-Silico、Ex-Vivo）
    • 按最终用户（製药业、化妆品和家用产品、学术机构和研究实验室、诊断、化学工业、食品工业）
    • 按公司划分 (2022)
    • 按地区
  • 市场地图

第 6 章：北美体外毒理学测试市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依技术
    • 按应用
    • 依方法
    • 按最终用户
    • 按国家/地区
  • 北美：国家分析
    • 美国
    • 墨西哥
    • 加拿大

第 7 章：欧洲体外毒理学测试市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依技术
    • 按应用
    • 依方法
    • 按最终用户
    • 按国家/地区
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 义大利
    • 西班牙

第 8 章：亚太体外毒理学测试市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依技术
    • 按应用
    • 依方法
    • 按最终用户
    • 按国家/地区
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲

第 9 章：南美洲体外毒理学测试市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依技术
    • 按应用
    • 依方法
    • 按最终用户
    • 按国家/地区
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲体外毒理学测试市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依技术
    • 按应用
    • 依方法
    • 按最终用户
    • 按国家/地区
  • MEA：国家分析
    • 南非体外毒理学测试
    • 沙乌地阿拉伯体外毒理学测试
    • 阿联酋体外毒理学测试

第 11 章：市场动态

  • 司机
  • 挑战

第 12 章：市场趋势与发展

  • 最近的发展
  • 产品发布
  • 併购

第 13 章：大环境分析

第 14 章：波特的五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 客户的力量
  • 替代产品的威胁

第15章：竞争格局

  • 商业概览
  • 公司概况
  • 产品与服务
  • 财务（上市公司）
  • 最近的发展
  • SWOT分析
    • Charles River Laboratories International, Inc.
    • SGS SA
    • Merck KGaA
    • Eurofins Scientific
    • Abbott Laboratories
    • Laboratory Corporation of America Holdings
    • Evotec SE
    • Thermo Fisher Scientific, Inc.
    • Quest Diagnostics Incorporated
    • Agilent Technolgies, Inc.
    • Catalent, Inc.

第 16 章：策略建议

简介目录
Product Code: 15986

The Global In-vitro Toxicology Testing Market reached a valuation of USD 16.09 Billion in 2022 and is projected to exhibit strong growth with a Compound Annual Growth Rate (CAGR) of 9.66% and expected to reach USD 27.88 Billion by 2028. In-vitro toxicology testing involves scientific processes to assess the potential toxic effects of various substances on biological systems outside living organisms. These evaluations are typically conducted in controlled laboratory settings using test tubes, culture dishes, or artificial systems, thus replicating the Latin term "in vitro," meaning "in glass." This approach provides insights into toxicological impacts at cellular, molecular, and biochemical levels, serving as a valuable tool in assessing chemical, drug, cosmetic, and consumer product safety without subjecting animals or humans to harm.

Key Market Drivers

Increasing Demand for New Drug and Chemical Safety Assessment

Market Overview
Forecast Period2024-2028
Market Size 2022USD 16.09 Billion
Market Size 2028USD 27.88 Billion
CAGR 2023-20289.66%
Fastest Growing SegmentCell Culture Technologies
Largest MarketNorth America

The escalating need for assessing the safety of new drugs and chemicals is a major driver for the Global In-vitro Toxicology Testing Market. Regulatory agencies such as the FDA and EMA demand comprehensive safety assessments for approval. In-vitro testing offers an efficient and cost-effective means to meet these requirements, considering ethical concerns and advancements in understanding. It aligns with reduced animal testing and accelerates safety evaluations in drug discovery.

Advancements in In-Vitro Toxicology Technologies

Technological progress in in-vitro toxicology is instrumental in market growth. Innovations in cell culture techniques, such as 3D models and organ-on-a-chip platforms, improve accuracy in mimicking tissue complexities. Automation, robotics, imaging technologies, and microfluidic devices enhance testing efficiency, predictive capabilities, and physiological relevance.

Increasing Awareness of Safety Testing Importance

Growing awareness among stakeholders about the necessity of safety assessments is a key trend driving the market. Ethical concerns, consumer awareness, regulatory guidelines, and media coverage prompt industries and researchers to prioritize safety evaluations. In-vitro testing gains prominence as a more socially responsible approach.

Key Market Challenges

Complexity of Biological Systems

Replicating intricate interactions within biological systems poses challenges. In-vitro models often fall short in reproducing systemic effects and complex physiological responses, limiting predictive accuracy.

Limited Relevance for Certain Endpoints

Some multifaceted toxicological endpoints may not be well-captured by in-vitro models. This limitation impacts the replacement of traditional animal testing and restricts application in specific regulatory and research contexts.

Long-Term and Chronic Effects

Assessing long-term and chronic effects using short-term in-vitro assays presents challenges. Complexities of chronic exposures and cumulative effects are difficult to replicate within limited time frames.

Key Market Trends

Personalized Medicine Applications

In-vitro toxicology aligns with personalized medicine trends, assessing individual responses to toxicants based on genetic and physiological characteristics. This approach aids risk assessments, informs treatment decisions, and identifies biomarkers for real-time toxicity monitoring.

Segmental Insights

Technology Insights

Reactive cell culture technology dominates the market due to its accuracy. Mimicking cellular responses in controlled environments facilitates toxicity testing across various compounds. This segment is projected to experience the highest CAGR, driven by advancements and applications.

Application Insights

Systemic toxicology testing leads the market as regulatory agencies demand comprehensive safety assessments. This approach predicts potential adverse effects on multiple organ systems without animal testing. It aids drug development and risk assessment.

Method Insights

Cellular assays are dominant due to their direct assessment of toxic effects on human cells. High-throughput capabilities and mechanistic insights into cellular pathways enhance efficiency and understanding.

End-User Insights

The pharmaceutical industry is a major end-user. Regulatory requirements, safety assessments, and early-stage risk identification drive in-vitro toxicity testing adoption in drug development.

Regional Insights

North America leads the market, supported by advanced pharmaceutical industries and stringent regulatory frameworks. Awareness of safety testing, ethical concerns, and technological advancements in the region contribute to growth.

Key Market Players

  • Charles River Laboratories International, Inc.
  • SGS S.A.
  • Merck KGaA
  • Eurofins Scientific
  • Abbott Laboratories
  • Laboratory Corporation of America Holdings
  • Evotec S.E.
  • Thermo Fisher Scientific, Inc.
  • Quest Diagnostics Incorporated
  • Agilent Technologies, Inc

Report Scope:

In this report, the Global In-vitro Toxicology Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below.

In-vitro Toxicology Testing Market, By Technology:

  • Cell Culture Technology
  • High Throughput Technology
  • Molecular Imaging
  • OMICS Technology

In-vitro Toxicology Testing Market, By Application:

  • Systemic Toxicology
  • Dermal Toxicity
  • Endocrine Disruption
  • Occular Toxicity
  • Others

In-vitro Toxicology Testing Market, By Method:

  • Cellular Assay
  • Biochemical Assay
  • In-silico
  • Ex-vivo

In-vitro Toxicology Testing Market, By End User:

  • Pharmaceutical Industry
  • Cosmetics & Household Products
  • Academic Institutes & Research Laboratories
  • Diagnostics
  • Chemicals Industry
  • Food Industry

Global In-vitro Toxicology Testing Market, By region:

  • North America
  • United States
  • Canada
  • Mexico
  • Asia-Pacific
  • China
  • India
  • South Korea
  • Australia
  • Japan
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global In-vitro Toxicology Testing Market.

Available Customizations:

  • Global In-vitro Toxicology Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global In-vitro Toxicology Testing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technology (Cell Culture Technology, High Throughput Technology, Molecular Imaging, OMICS Technology)
    • 5.2.2. By Application (Systemic Toxicology, Dermal Toxicity, Endocrine Disruption, Occular Toxicity, Others)
    • 5.2.3. By Method (Cellular Assay, Biochemical Assay, In-Silico, Ex-Vivo)
    • 5.2.4. By End-User (Pharmaceutical Industry, Cosmetics & Household Products, Academic Institutes & Research Laboratories, Diagnostics, Chemicals Industry, Food Industry)
    • 5.2.5. By Company (2022)
    • 5.2.6. By Region
  • 5.3. Market Map

6. North America In-vitro Toxicology Testing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technology
    • 6.2.2. By Application
    • 6.2.3. By Method
    • 6.2.4. By End-User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States In-vitro Toxicology Testing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Technology
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By Method
        • 6.3.1.2.4. By End-User
    • 6.3.2. Mexico In-vitro Toxicology Testing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Technology
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By Method
        • 6.3.2.2.4. By End-User
    • 6.3.3. Canada In-vitro Toxicology Testing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Technology
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By Method
        • 6.3.3.2.4. By End-User

7. Europe In-vitro Toxicology Testing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technology
    • 7.2.2. By Application
    • 7.2.3. By Method
    • 7.2.4. By End-User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France In-vitro Toxicology Testing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Technology
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By Method
        • 7.3.1.2.4. By End-User
    • 7.3.2. Germany In-vitro Toxicology Testing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Technology
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By Method
        • 7.3.2.2.4. By End-User
    • 7.3.3. United Kingdom In-vitro Toxicology Testing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Technology
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By Method
        • 7.3.3.2.4. By End-User
    • 7.3.4. Italy In-vitro Toxicology Testing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Technology
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By Method
        • 7.3.4.2.4. By End-User
    • 7.3.5. Spain In-vitro Toxicology Testing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Technology
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By Method
        • 7.3.5.2.4. By End-User

8. Asia-Pacific In-vitro Toxicology Testing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technology
    • 8.2.2. By Application
    • 8.2.3. By Method
    • 8.2.4. By End-User
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China In-vitro Toxicology Testing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Technology
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By Method
        • 8.3.1.2.4. By End-User
    • 8.3.2. India In-vitro Toxicology Testing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Technology
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By Method
        • 8.3.2.2.4. By End-User
    • 8.3.3. South Korea In-vitro Toxicology Testing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Technology
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By Method
        • 8.3.3.2.4. By End-User
    • 8.3.4. Japan In-vitro Toxicology Testing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Technology
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By Method
        • 8.3.4.2.4. By End-User
    • 8.3.5. Australia In-vitro Toxicology Testing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Technology
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By Method
        • 8.3.5.2.4. By End-User

9. South America In-vitro Toxicology Testing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technology
    • 9.2.2. By Application
    • 9.2.3. By Method
    • 9.2.4. By End-User
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil In-vitro Toxicology Testing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Technology
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By Method
        • 9.3.1.2.4. By End-User
    • 9.3.2. Argentina In-vitro Toxicology Testing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Technology
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By Method
        • 9.3.2.2.4. By End-User
    • 9.3.3. Colombia In-vitro Toxicology Testing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Technology
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By Method
        • 9.3.3.2.4. By End-User

10. Middle East and Africa In-vitro Toxicology Testing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technology
    • 10.2.2. By Application
    • 10.2.3. By Method
    • 10.2.4. By End-User
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa In-vitro Toxicology Testing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Technology
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By Method
        • 10.3.1.2.4. By End-User
    • 10.3.2. Saudi Arabia In-vitro Toxicology Testing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Technology
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By Method
        • 10.3.2.2.4. By End-User
    • 10.3.3. UAE In-vitro Toxicology Testing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Technology
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By Method
        • 10.3.3.2.4. By End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Product

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Company Snapshot
  • 15.3. Products & Services
  • 15.4. Financials (In case of listed companies)
  • 15.5. Recent Developments
  • 15.6. SWOT Analysis
    • 15.6.1. Charles River Laboratories International, Inc.
    • 15.6.2. SGS S.A.
    • 15.6.3. Merck KGaA
    • 15.6.4. Eurofins Scientific
    • 15.6.5. Abbott Laboratories
    • 15.6.6. Laboratory Corporation of America Holdings
    • 15.6.7. Evotec S.E.
    • 15.6.8. Thermo Fisher Scientific, Inc.
    • 15.6.9. Quest Diagnostics Incorporated
    • 15.6.10. Agilent Technolgies, Inc.
    • 15.6.11. Catalent, Inc.

16. Strategic Recommendations